Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-03-12
DOI
10.1002/jcp.28451
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of epigenetic therapies in colorectal cancer
- (2018) Marina Baretti et al. CURRENT PROBLEMS IN CANCER
- Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer
- (2018) Akira Okita et al. Oncotarget
- Arginine Methylation Regulates MEIS2 Nuclear Localization to Promote Neuronal Differentiation of Adult SVZ Progenitors
- (2018) Jasmine Kolb et al. Stem Cell Reports
- Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma
- (2018) Wei Xu et al. PLoS One
- FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3β-related pathways
- (2018) Yan-Feng Huang et al. Oncogenesis
- Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis
- (2018) Jianing Tang et al. Frontiers in Oncology
- Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer
- (2018) Peng-Fei Chen et al. OncoTargets and Therapy
- Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells
- (2017) Lilly Y. W. Bourguignon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance
- (2017) Ji-Hak Jeong et al. MOLECULAR CELL
- XELOXvs.FOLFOX in metastatic colorectal cancer: An updated meta-analysis
- (2016) Yu Guo et al. CANCER INVESTIGATION
- Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers
- (2016) Satoshi Nagayama et al. International Journal of Clinical Oncology
- MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML
- (2016) Naidu M. Vegi et al. Cell Reports
- Induction of Epithelial-Mesenchymal Transition and Down-Regulation of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells
- (2015) Shota Tanaka et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG)
- (2015) Joost Huiskens et al. BMC CANCER
- Cancer stem cells in progression of colorectal cancer
- (2015) Yujuan Zhou et al. Oncotarget
- Molecular Aspects of Resistance to Biological and Non-Biological Drugs and Strategies to Overcome Resistance in Colorectal Cancer
- (2014) T. Troiani et al. CURRENT MEDICINAL CHEMISTRY
- MEIS2 is essential for neuroblastoma cell survival and proliferation by transcriptional control of M-phase progression
- (2014) Y Zha et al. Cell Death & Disease
- MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers
- (2013) Xu Qian et al. CELL CYCLE
- Identification of HOXB8 and KLK11 expression levels as potential biomarkers to predict the effects of FOLFOX4 chemotherapy
- (2013) Shaotang Li et al. Future Oncology
- Deregulation of a Hox Protein Regulatory Network Spanning Prostate Cancer Initiation and Progression
- (2012) J. L. Chen et al. CLINICAL CANCER RESEARCH
- SNAIL Regulates Interleukin-8 Expression, Stem Cell–Like Activity, and Tumorigenicity of Human Colorectal Carcinoma Cells
- (2011) Wei–Lun Hwang et al. GASTROENTEROLOGY
- Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells
- (2011) Maria Ausiliatrice Puglisi et al. JOURNAL OF PATHOLOGY
- Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
- (2010) Michel Ducreux et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- The Role of MMP7 and Its Cross-Talk with the FAS/FASL System during the Acquisition of Chemoresistance to Oxaliplatin
- (2009) Vanessa Almendro et al. PLoS One
- WGCNA: an R package for weighted correlation network analysis
- (2008) Peter Langfelder et al. BMC BIOINFORMATICS
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
- Geometric Interpretation of Gene Coexpression Network Analysis
- (2008) Steve Horvath et al. PLoS Computational Biology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation